MNTK Surges 26.7% as EPS Revisions Signal Renewables Strength
Montauk Renewables (MNTK) led the pack with a 26.7% surge to $2.23 after its forward EPS growth estimate hit 35.3% in early September. Faeth Therapeutics (FTH) climbed 18.4% to $40.05 following a 1.2pp upward revision to 78.7% EPS growth. Robinhood (HOOD) gained 18.0% to $122.11 as analysts turned bullish and crypto rallied.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| MNTK | Basic Materials | 2026-09-01 | N/A | +26.7% |
| FTH | Healthcare | 2026-08-30 | +1.2pp | +18.4% |
| HOOD | Financial | 2026-09-01 | N/A | +18.0% |
| GOTU | Consumer Defensive | 2026-08-30 | +187.3pp | +17.0% |
| GEMI | Financial | 2026-09-01 | N/A | +12.5% |
Why did MNTK stock jump in September 2026?
MNTK surged 26.7% from $1.76 to $2.23 after its forward EPS growth estimate was raised to 35.3% on September 1, signaling improved profitability expectations for the renewable energy firm.
The stock's rally outpaced its basic materials sector peers, likely buoyed by broader tailwinds in the renewables space as the market prices in higher future earnings. The screener flagged MNTK early, and the subsequent price action confirms that investors are rewarding the upgraded outlook. No earnings-related news appeared in the window, leaving the EPS revision as the primary catalyst behind the move.
MNTK EPS revision history → · Screener snapshot from 2026-09-01 →
FAQ: MNTK
Why did MNTK stock jump?
MNTK jumped 26.7% from $1.76 to $2.23 after its forward EPS growth estimate was revised to 35.3% on September 1, reflecting improved profitability expectations.
Is MNTK a buy after the rally?
The rally reflects strong EPS revision momentum, but investors should validate the 35.3% growth estimate against sector and company fundamentals before buying.
What caused MNTK's surge?
The surge was driven by an upward EPS revision for next year to 35.3% growth, detected on September 1, without any offsetting earnings news.
Why did FTH stock jump in September 2026?
FTH jumped 18.4% from $33.84 to $40.05 after analysts raised its next-year EPS growth estimate from 77.6% to 78.7% on August 30.
The healthcare stock's rally highlights investor confidence in its growth trajectory, despite the absence of earnings-related news in the following week. The positive EPS revision likely reflects improved clinical or operational outlook, and the market's response underscores the materiality of the upgrade. The screener's early detection captured the move before the full price adjustment.
FTH EPS revision history → · Screener snapshot from 2026-08-30 →
FAQ: FTH
Why did FTH stock jump?
FTH jumped 18.4% to $40.05 after analysts revised its next-year EPS growth estimate up by 1.2 percentage points to 78.7% on August 30.
What caused FTH's surge?
The surge was ignited by an upward EPS revision for next year, signaling stronger potential earnings and triggering a positive market reaction.
What is FTH's EPS growth estimate?
FTH's next-year EPS growth estimate is now 78.7%, up from 77.6% in the recent revision.
Why did HOOD stock jump in September 2026?
HOOD jumped 18.0% from $103.51 to $122.11 after analysts raised its forward EPS growth estimate to 34.2% on September 1, a period marked by a wider crypto rally.
The stock's surge, which made it the S&P 500's top gainer on September 3, was amplified by upgrades from Morgan Stanley and Scotiabank, along with a price target hike from Piper Sandler. Bitcoin's climb toward $81,500 and Robinhood's expanding product offerings provided additional tailwinds, reaffirming the market's belief in the EPS revision's accuracy. This combined narrative of estimate revision and analyst upgrades drove outsized gains.
HOOD EPS revision history → · Screener snapshot from 2026-09-01 →
FAQ: HOOD
Why did HOOD stock jump?
HOOD jumped 18.0% to $122.11 after its forward EPS growth estimate was revised to 34.2% on September 1, with analyst upgrades and a crypto rally amplifying the move.
Is HOOD a buy after the rally?
With EPS growth expected at 34.2% and analysts raising price targets, the outlook appears positive, but the stock's rally already reflects much of this optimism.
What caused HOOD's surge?
The surge was driven by an upward EPS revision, plus upgrades from Morgan Stanley and Scotiabank, and rising Bitcoin prices that benefited Robinhood's crypto-linked revenue.
Why did GOTU stock jump in September 2026?
GOTU gained 17.0% from $1.88 to $2.20 after its next-year EPS growth estimate was dramatically raised from 2722.7% to 2910.0% on August 30, reflecting a massive turnaround in profitability expectations.
The consumer defensive stock's rally suggests investors are betting on a stronger earnings recovery, with the upgrade representing a crushing positive signal for the company's future. Despite the lack of earnings-related news, the sheer scale of the EPS revision (a +187.3pp change) appears to have driven the move. GOTU's performance underscores how even single-stock revisions can produce outsized moves in volatile ADRs.
GOTU EPS revision history → · Screener snapshot from 2026-08-30 →
FAQ: GOTU
Why did GOTU stock jump?
GOTU jumped 17.0% to $2.20 after its next-year EPS growth estimate was upgraded by 187.3 percentage points to 2910.0% on August 30.
What caused GOTU's surge?
The surge was triggered by a massive upward revision in EPS growth expectations, signaling a sharp turnaround in profitability.
What is GOTU's EPS growth estimate?
GOTU's next-year EPS growth estimate stands at 2910.0%, up from 2722.7% in the recent revision.
Why did GEMI stock jump in September 2026?
GEMI rose 12.5% from $4.16 to $4.68 after its forward EPS growth estimate was set at 25.9% on September 1, a positive signal for the financial sector stock.
The company, tied to space station infrastructure, benefited as investors digested the upgraded earnings expectations, even without direct earnings-related news. The move aligns with growing sentiment in space economy plays, where future revenue visibility is improving. The screener flagged this revision early, and the price action confirms market confidence in the estimate.
GEMI EPS revision history → · Screener snapshot from 2026-09-01 →
FAQ: GEMI
Why did GEMI stock jump?
GEMI jumped 12.5% to $4.68 after its forward EPS growth estimate was set at 25.9% on September 1, signaling improved profitability.
Is GEMI a buy after the rally?
With EPS growth projected at 25.9%, the stock could have further upside, but investors should assess the sustainability of the revision.
What caused GEMI's surge?
The surge was fueled by an upward EPS revision for next year, with no earnings-related news in the window, highlighting the revision's importance.
Today's top performers were all driven by upward EPS revisions, with gains ranging from 12.5% to 26.7%, underscoring that earnings estimate momentum remains a powerful catalyst. Even in the absence of news, the market rewarded these revised expectations, signaling a constructive outlook for companies with improving fundamentals.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →